In today’s recent session, 0.5 million shares of the Vaxcyte Inc (NASDAQ:PCVX) have been traded, and its beta is 1.24. Most recently the company’s share price was $32.38, and it changed around -$0.16 or -0.49% from the last close, which brings the market valuation of the company to $4.18B. PCVX at last check was trading at a discount to its 52-week high of $121.06, offering almost -273.87% off that amount. The share price’s 52-week low was $27.66, which indicates that the recent value has risen by an impressive 14.58% since then. We note from Vaxcyte Inc’s average daily trading volume that its 10-day average is 2.17 million shares, with the 3-month average coming to 2.39 million.
Vaxcyte Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 10 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended PCVX as a Hold, whereas 9 deemed it a Buy, and 0 rated it as Underweight.
Vaxcyte Inc (NASDAQ:PCVX) trade information
Instantly PCVX has been showing red trend so far today with a performance of -0.49% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 36.84 on recent trading dayincreased the stock’s daily price by 12.11%. The company’s shares are currently down -60.44% year-to-date, but still up 1.09% over the last five days. On the other hand, Vaxcyte Inc (NASDAQ:PCVX) is -1.64% down in the 30-day period. We can see from the shorts that 12.04 million shares have been sold at a short interest cover period of 3.27 day(s).
The consensus price target as assigned by Wall Street analysts is $140, which translates to bulls needing to increase their stock price by 76.87% from its current value. Analyst projections state that PCVX is forecast to be at a low of $58 and a high of $163.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -29.88%. Vaxcyte Inc earnings are expected to increase by -24.44% in 2025, but the outlook is negative -7.11% per year for the next five years.
PCVX Dividends
Vaxcyte Inc’s next quarterly earnings report is expected to be released on 2025-May-06.
Vaxcyte Inc (NASDAQ:PCVX)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.66% of Vaxcyte Inc shares, and 117.68% of them are in the hands of institutional investors. The stock currently has a share float of 118.47%. Vaxcyte Inc stock is held by 457.0 institutions, with FMR LLC being the largest institutional investor. By 2024-06-30, it held 13.788% of the shares, which is about 16.17 million shares worth $1.22 billion.
BLACKROCK INC., with 8.477% or 9.94 million shares worth $750.56 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF were the top two Mutual Funds as of Dec 31, 2024 . The former held 3.74 shares worth $121.53 million, making up 2.90% of all outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held roughly 3.26 shares worth around $106.07 million, which represents about 2.53% of the total shares outstanding.
